ACUREX BIOSCIENCES
Live / Registered — Registered (as of 25 Feb 2025)
What this means for you
Registered since 25 Feb 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90981351
- Registration number
- 7706735
- Mark type
- Stylized text
- Filed
- 21 Dec 2020
- Published for opposition
- 26 Oct 2021
- Registered
- 25 Feb 2025
- Attorney of record
- KAREN WON
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development services in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; providing medical and scientific research and information in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's Disease, Alzheimer's, ALS, Huntington's, and diseases of aging; medical diagnostic research and pharmaceutical development services for drug discovery in the fields of neurological, central nervous system, mitochondrial, and metabolic diseases and disorders, Parkinson's, Alzheimer's, ALS, Huntington's, and diseases of aging
Owner
- ACUREX BIOSCIENCES CORPORATION, SAN CARLOS, CA, US
- ACUREX BIOSCIENCES CORPORATION, SAN CARLOS, CA, US
- AcureX Therapeutics Corporation, San Carolos, CA, US
- AcureX Therapeutics Corporation, San Carolos, CA, US
Prosecution history
- 25 Feb 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Feb 2025 — REGISTERED-PRINCIPAL REGISTER
- 01 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 01 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 18 Jan 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 17 Jan 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Sept 2024 — USE AMENDMENT FILED
- 17 Jan 2025 — SOU EXTENSION 3 GRANTED
- 29 Sept 2024 — SOU EXTENSION 3 FILED
- 17 Jan 2025 — DIVISIONAL PROCESSING COMPLETE
- 29 Sept 2024 — DIVISIONAL REQUEST RECEIVED
- 17 Jan 2025 — REVIEW OF CORRESPONDENCE COMPLETE
- 10 Dec 2024 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Sept 2024 — TEAS REQUEST TO DIVIDE RECEIVED
- 29 Sept 2024 — TEAS REQUEST TO DIVIDE RECEIVED